This year the conference will highlight the role of genomic evidence – from internal and external environments as well as its role in the detection, tracking and control of antimicrobial resistance, especially in low- and middle-income countries.
Topics will include:
- Global burden of disease from drug-resistant infections: monitoring and evaluation
- Genomic evidence that informs the debate on the role of external and internal environments in AMR
- Genomic surveillance and epidemiology: its role in detection, tracking and control of antimicrobial resistance in LMIC
- Vaccines against AMR
- Translating bacterial genomics and metagenomics into clinical practice